Advertisement
U.S. markets closed

Enanta Pharmaceuticals, Inc. (ENTA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
17.46+0.93 (+5.63%)
At close: 04:00PM EDT
17.46 0.00 (0.00%)
After hours: 04:03PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close16.53
Open16.71
Bid17.40 x 200
Ask17.53 x 200
Day's Range16.50 - 17.76
52 Week Range8.08 - 41.45
Volume299,052
Avg. Volume276,613
Market Cap369.384M
Beta (5Y Monthly)0.44
PE Ratio (TTM)N/A
EPS (TTM)-6.57
Earnings DateMay 06, 2024 - May 10, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est22.29
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ENTA

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Enanta Pharmaceuticals, Inc.
    ENTA: Lowering target price to $10.00ENANTA PHARMACEUTICALS INC has an Investment Rating of SELL; a target price of $10.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    6 months agoArgus Research
View more